Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inwards

Showing results (351-360 of 382) with videos related to

Pageof 39
Sort By:
British Journal of Haematology|March 19, 2016
Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantationTimothy S Fenske, Kwang W Ahn, Tara M Graff, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2011
Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failureCésar O Freytes, Mei-Jie Zhang, Jeanette Carreras, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 2, 2008
Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR)Hillard M Lazarus, Jeanette Carreras, Christian Boudreau, et al.
The American Journal of Surgical Pathology|January 7, 2004
Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literatureAndrew L Folpe, Julie C Fanburg-Smith, Steven D Billings, et al.
Blood|May 31, 2024
Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCLMitchell R Smith, Opeyemi A Jegede, Peter Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2018
Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical TrialsMatthew J Maurer, Hervé Ghesquières, Brian K Link, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 8, 2010
A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTRHillard M Lazarus, Mei-Jie Zhang, Jeanette Carreras, et al.
Journal of Hematology & Oncology|January 12, 2019
Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: a CIBMTR analysisNarendranath Epperla, Kwang W Ahn, Carlos Litovich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2014
Active idiotypic vaccination versus control immunotherapy for follicular lymphomaRonald Levy, Kristen N Ganjoo, John P Leonard, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|June 22, 2016
Hypoxia-related microRNA-210 is a diagnostic marker for discriminating osteoblastoma and osteosarcomaScott M Riester, Jorge Torres-Mora, Amel Dudakovic, et al.
Pageof 39

Showing results (351-360 of 382) with videos related to

Sort By:
Pageof 39
British Journal of Haematology|March 19, 2016
Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantationTimothy S Fenske, Kwang W Ahn, Tara M Graff, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2011
Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failureCésar O Freytes, Mei-Jie Zhang, Jeanette Carreras, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 2, 2008
Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR)Hillard M Lazarus, Jeanette Carreras, Christian Boudreau, et al.
The American Journal of Surgical Pathology|January 7, 2004
Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literatureAndrew L Folpe, Julie C Fanburg-Smith, Steven D Billings, et al.
Blood|May 31, 2024
Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCLMitchell R Smith, Opeyemi A Jegede, Peter Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2018
Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical TrialsMatthew J Maurer, Hervé Ghesquières, Brian K Link, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 8, 2010
A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTRHillard M Lazarus, Mei-Jie Zhang, Jeanette Carreras, et al.
Journal of Hematology & Oncology|January 12, 2019
Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: a CIBMTR analysisNarendranath Epperla, Kwang W Ahn, Carlos Litovich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2014
Active idiotypic vaccination versus control immunotherapy for follicular lymphomaRonald Levy, Kristen N Ganjoo, John P Leonard, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|June 22, 2016
Hypoxia-related microRNA-210 is a diagnostic marker for discriminating osteoblastoma and osteosarcomaScott M Riester, Jorge Torres-Mora, Amel Dudakovic, et al.
Pageof 39